The present invention relates to the following compounds
wherein the integers are as defined in the description, and where the compounds may be useful as medicaments, for instance for use in the treatment of tuberculosis.
US4468526A
申请人:——
公开号:US4468526A
公开(公告)日:1984-08-28
TaMe<sub>3</sub>Cl<sub>2</sub>-Catalyzed Intermolecular Hydroaminoalkylation: A Simple Complex for Enhanced Reactivity and Expanded Substrate Scope
作者:Zhengxing Zhang、Jean-Denys Hamel、Laurel L. Schafer
DOI:10.1002/chem.201300992
日期:2013.7.1
Tantalizingly simple: The common organometallic starting material TaMe3Cl2 can be used for the catalytic CH functionalization reaction, hydroaminoalkylation. The substrate scope for this readily accessed compound includes unactivated terminal and internal alkenes, styrene derivatives, and both alkylaryl‐ and dialkyl secondary amines (see scheme).